Contemporary Oral Oncology

Moni Abraham Kuriakose, BSc, BDS, MB ChB, MD, FDSRCS, FFDRCS, FRCS Ed, FRCS (Maxillofacial Surgery), is Director of the Translational Research Program and Attending Surgeon in the Department of Head and Neck/Plastic and Reconstructive Surgery at the Roswell Park Cancer Institute, Buffalo, New York, and Professor of Surgery, Director of the Department of Surgical Oncology, and Chief of the Division of Head and Neck Oncology at the Mazumdar-Shaw Cancer Center, Narayana Health City, Bangalore, India. In addition, he is Adjunct Associate Professor in the Departments of Oral and Maxillofacial Surgery and Otolaryngology at New York University. Dr. Kuriakose has received numerous honors and awards and has held many national and international leadership positions, including as Chairman of the Oral Cancer Special Interest Group, International Association of Oral and Maxillofacial Surgeons (2008-2012), Secretary General of the International Academy of Oral Oncology (2013-2015) and President of Indian Head and Neck Oncology Society (2015-2017). He is a member of the editorial boards for Oral Oncology and the Journal of Maxillofacial and Oral Surgery, and a reviewer for a number of other leading journals. Dr. Kuriakose's research group focuses on two key challenges: down-staging and prevention of oral cancer; and reversing chemotherapy resistance. He has been the principal investigator on many research projects and is the author of over 150 peer-reviewed publications.

Clinical Evaluation and Staging of Oral Cancer.-Imaging of Oral Cavity Cancer.- General Principles and Management Guidelines in Oral Cavity Cancer.- Radiation Therapy in Oral Cavity Cancer.- Current and Emerging Roles of Chemotherapy in Oral Cavity Cancer.- An Overview of Ablative Surgery in Oral Cavity Cancer.- Management of the Neck in Oral Cavity Cancer.- Sentinel Lymph Node Biopsy for Early Stage Oral Cavity Cancer.- Management of Complications of Management of Oral Cancer.- Salvage Treatment for Recurrent Oral Cancer.- Understanding Therapy Failures and Emerging Approaches to Improve Outcomes.- Rare Tumors of the Oral Cavity.